Abstract-Effect of the aqueous extract of Cinnamomum Cassia (CCAq) on experimental allergic reaction was investigated. IgE mediated reactions, homologous passive cutaneous anaphylaxis (PCA), degranulation of mast cells, and the release of histamine from sensitized lung tissues classified as the type I reaction by Coombs and Gell were not affected by CCAq. Com plement dependent reactions including reversed cutaneous anaphylaxis (RCA), Forssman cutaneous vasculitis (FCV), and nephrotoxic serum (NTS) nephritis classified as type II and the Arthus reaction classified as type III were clearly inhibited by CCAq. However, CCAq did not affect the nephritis caused by the F(ab')2 portion of the nephrotoxic IgG antibody. CCAq in a high concentration inhibited the immunological hemolysis, chemotactic migration of neutrophils in response to complement activated serum, and the generation of chemotactic factors. The type IV reaction, contact dermatitis, was not affected by CCAq. The production of hemolytic plaque forming cells was slightly inhibited by CCAq. These results suggest that CCAq has an anticomplement action and inhibits the complement dependent allergic reaction.
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Cinnamomi
Cortex is one of the most important crude medicines which has been often used in many Chinese manuscripts. The chemical and pharmacological studies of Cinnamomi Cortex have mainly been per formed on its essential oil or cinnamic aldehyde. Their pharmacological actions so far reported are the depressive actions on the central nervous system, circulating system, or gastrointestinal system (1, 2) . We have been studying the anti-allergic action of aqueous or alcholic extracts of some Chinese medicines and their components (3) (4) (5) (6) . However, there have been few opportunities for investigating the anti-allergic action of Cinnamomi Cortex. In the present study, we have studied the effect of the aqueous extract of Cinnamomum Cassia (CCAq) on experimental allergic reactions according to the classification by Coombs and Gell (7).
MATERIALS AND METHODS

Animals:
Male ddY mice weighing 18 to 20 g, male Wistar rats weighing 120 to 180 g, Hartley guinea pigs of both sexes weighing 350 to 400 g, and male Albino rabbits weighing 2 to 3 kg were used.
Drugs: CCAq was prepared as follows:
One hundred g of finely ground Cinnamomum Cassia was extracted with 1 I of distilled water by heating at 60°C for 4 hr. After filtration, the aqueous extract was concen trated by evaporation at a temperature under 30°C. The extract was kept at -20°C until use. N-(3',4'-dimethoxycinnamoyl) an thranilic acid (N-5') was kindly provided by the Kissei Pharmaceutical Co. Ltd., Matsu moto, Japan. Cobra venom factor (CoVF) and prednisolone phosphate were purchased from Cordis Laboratories, Fla., U.S.A. and the Nakarai Pharmaceutical Co. Ltd., Osaka, Japan.
Homologous passive cutaneous ana phylaxis (PCA) in rats: Homologous PCA in rats was carried out according to the method previously described (8) . Antiserum containing homocytotropic antibody was obtained from rats that had been immunized with 2,4-dinitrophenyl-coupled ascaris (DNP As) mixed with killed Bordetella pertussis according to Tada and Okumura (9) . The antiserum diluted 17-fold with physiologic saline was injected intradermally in a 0.1 ml dose into 4 sites on the shaved backs of normal rats. After 48 hr, 1 ml of 0.25% Evans blue solution containing 2.0 mg of antigen was injected into the rats. Thirty min later, the animals were sacrificed by ex sanguination, and the skins were removed to measure the PCA bluing lesion. The amount of the dye was them estimated colon metrically after extraction with 1.0 N KOH and the mixture of acetone and phosphoric acid by the method of Katayama et al. (10) .
Degranulation
of mast cells in the rat mesenterium:
The experiment concerning degranulation was carried out essentially according to the method of Yamasaki and Saeki (11) . In brief, mesenterium isolated from the normal rat was passively sensitized with rat anti-DNP-As serum in vitro. After washing the mesenterium by physiologic saline, the sensitized mesenterium was incubated with 10-4 g/ml DNP-As as an antigen at 37'C for 20 min. The reaction was stopped by addition of a few drops of 10% formalin. Mast cells in the mesenterium were stained with 0.1% toluidin blue, and number of degranulated cells was counted under a microscope.
Histamine release from sensitized guinea pig lung: Guinea pigs were passively sensi tized by intravenous injection of antiserum containing a homocytotropic antibody.
Guinea pig homocytotropic antibody was made by the method of Levine et al. (12) using benzylpenicilloyl bovine r-globulin (BPO BGG) mixed with alum as the antigen and adjuvant, respectively.
Five hundred mg of chopped lung tissue obtained from passively sensitized guinea pigs was suspended in 4.0 ml Tyrode's solution and warmed for 5 min at 37°C. The drugs tested in a volume of 0.5 ml were added to the reaction mixture at 20 min prior to the incubation with antigen. Antigen in a volume of 0.5 ml of 0.1% BPO BGG was added and incubated for 20 min. The amount of histamine in the incubation medium was assayed by a fluorescence method according to May et al. (13) .
Reversed cutaneous anaphylaxis (RCA): Measurement was done according to the method of Ungar et al. (14) . The lyophilized rabbit anti rat serum was dissolved in 1 % Evans blue to make a 14% solution. This solution was injected i.d. in a 0.05 ml dose. The same dose of physiologic saline con taining 1 % Evans blue was similarly injected. Two hr thereafter, the animals were sacrificed by exsanguination, and the skin removed. The inflamed areas were cut out with a leather punch (12 mm in diameter), and the skin discs thus obtained were weighed. The weights of the inflamed skin discs were compared with that of the saline treated skin.
Forssman cutaneous vasculitis (FCV): FCV was carried out according to the method described previously (5) . Guinea pigs were injected with 0.1 ml of rabbit anti-sheep red blood cell (SRBC) serum diluted 8-fold with physiologic saline i.d. into their shaved backs, followed by an i.v. injection of 1.0 ml of 1 % Evans blue. After 1 hr, the animals were sacrificed by exsanguination, and the skin was removed. The blueing spot caused by the FCV was measured by the same method as was used for PCA.
Complement activity: Hemolytic activity of complement by classical pathway was measured according to the method of Nishioka and Okada (15) . In brief, 5 x 108/mI SRBC sensitized with hemolysin were added to the mixture of 5.5 ml gelatin veronal buffer and 1.0 ml guinea pig serum, adjusted as 1 unit of CH50, and incubated at 37°C for 1 hr. The reaction was stopped by cooling the test tubes with ice water. The mixture was centrifuged, and the supernatant was assayed colorimetrically at 541 nm. Hemolytic activity of complement by the alternative pathway was measured by the method of Platts-Mills and Ishizaka (16) . Four hundred ELI of human serum diluted with gelatin veronal buffer containing 0.008 M ethylene glycol bis amino tetraacetate (EGTA) was added to 0.2 ml of rabbit red cells at O 'C. The mixture was incubated at 37'C for 30 min with frequent shaking. After incubation, 2.5 ml of cold gelatin veronal buffer containing 0.01 M ethylenediamine tetraacetate (EDTA) was added. The reaction mixture was centrifuged and the supernatant was assayed colori metrically at 412 nm.
Generation of the chemotactic factor from guinea pig complement: Measurement was done by the method of Ward et al. (17) . One ml of guinea pig serum and 2.5 mg zymosan were mixed, and then the mixture was incubated at 37 °C for 1 hr with gentle rotation. After incubation, the reaction mixture was centrifuged at 1,000 rpm for 10 min, and the supernatant was incubated at 56'C for 30 min. The chemotactic activity of the supernatant to guinea pig neutrophils was assayed using a modified Boyden chamber (Sanki-Kogei Co. Ltd., Tokyo) with a Millipore filter (pore size, 0.65 u). Nephrotoxic serum (NTS) nephritis: Glomerulonephritis was induced in rats by intravenous injection of 0.5 ml of rabbit anti-serum against rat kidney glomerular basement menbrane (NTS) or 2.0 ml of the F(ab')2 portion of its IgG, respectively. NTS was prepared according to the method of Shibata et al. (18) . IgG from NTS and the F(ab')2 of IgG were prepared according to the method of Nisonoff et al. (19) . In order to measure the severity of the disease, rats were kept in metabolic cages, and their urine was collected. Urinary protein was determined by the method of Kingsbury et al. (20) using sulfosalicylic acid. The serum complement level was assayed by the ultramicrotitration method described by Irie et al. (21) . Histolo gical studies of the kidney were performed under the light microscope after staining with hematoxylin-eosin (HE) or periodinate Shiff (PAS) and assessed in a semiquanti tative fashion with a score of 0 to 3 according to the method of Litwin et al. (22) .
Arthus reaction: Rabbits were immunized by injecting 10 mg of bovine serum albumin (BSA) emulsified in complete Freund's adjuvant Lm. 4 times weekly. Ten days after the last injection, 0.2 ml of 1 % antigen was injected i.d. into 8 sites on the shaved backs of the animals. At 1, 2, 3, 5, 8, 12, and 24 hr after injection, the dimensions of the inflamed areas were measured macroscopically.
Contact dermatitis in guinea pigs: This experiment was carried out according to the method described previously (8) . Guinea pigs were sensitized by iontophoresis of p phenylenediamine (p-PD). lontophoresis was performed by allowing 1 mA current to pass for 15 min. A gauze soaked with p-PD solution served as an anode on the neck, and the same size gauze soaked with physiologic saline served as an cathode on the abdomen. This procedure was repeated 6 times every other day. After 4 weeks, the animals were given 0.05 ml of 2% p-PD as an antigen i.d. into the shaved back skin. Twenty-two hr after the antigen treatment, 1.0 ml of 1 % Evans blue was injected i.v. The animals were sacrificed in 2 hr, and the skins removed. The amount of dye was determined by the same method as used for PCA.
The production of hemolytic plaque forming cells (HPFC) in mice spleen: The method of Cunningham and Szenberg was followed (23). Mice were immunized by i.v. injection with 2x108 SRBC. Five days later, the animals were sacrificed, and the spleen was expanded for preparing a single cell suspension with 150 mesh stainless sieves. One hundred ILI of the single cell suspension, 450 /fl of 7.5x108 cells/ml S R BC suspension, and 450 al of 10% guinea pig serum were mixed, and a Cunningham chamber was filled with the mixture. After 1 hr incubation at 37 °C, the number of H PFC was counted macroscopically.
RESULTS
Homologous
PCA in rats: The effect of CCAq on homologous PCA in rats was compared with that of N-5' which had been found as a potent inhibitor of the type I reaction in our laboratory (8 Values (amount of dye) are presented as the means±S.E. of 6 animals. Significant difference from control by the t-test at *: P<0.05 and t: P<0.01 terium: The effects of CCAq and N-5' on the degranulation of mast cells were tested by treating the mesenterium with drugs for 20 min before the challenge. As shown in Table 2 , degranulation of mast cells was not affected by CCAq, but it was significantly inhibited by N-5' at a concentration of 10-4 g/ ml (P<0.05).
Histamine release from sensitized guinea pig lung: The amount of histamine released by antigen was calculated by subtracting the amount spontaneously released from each value. As shown in Table 3 , the release of histamine was not affected by CCAq at concentrations of 10-6 to 10-4 g/ml and N-5' at a concentration of 10-5 g/ml. How ever, N-5' at a concentration of 10-4 g/ml showed a significant inhibition of the hista mine release (P<0.01).
RCA and FCV: The effects of CCAq on RCA and FCV were compared with that of prednisolone. CCAq at doses of 50 to 200 mg/ kg and prednisolone at 1 to 10 mg/kg were administered i.p. and p.o., respectively, 1 hr prior to challenge. As shown in Table 4 , RCA was significantly inhibited by CCAq in a dose of 200 mg/kg (P<0.05) and prednisolone in a dose of 10 mg/kg (P<0.05).
FCV was also inhibited by both drugs in the same doses as used for RCA (P<0.01). Values (amount of released histamine) are presented as the means±S.E. of 4 experiments. Significant difference from control by the t-test, t: P<0.01 Table 4 . Effect of CCAq and prednisolone on reversed cutaneous anaphylaxis (RCA) in rats and Forssman cutaneous vasculitis (FCV) in guinea pigs.
. Table 5 . CCAq in concentrations of 10-4 to 10-3 g/ml inhibited the comple ment activity activated by both pathways. Generation of the chemotactic factor: To determine the effect of CCAq on generation of the chemotactic factor and chemotaxis, CCAq was added to the mixture of guinea pig complement and zymosan at different times. As shown in Table 6 , chemotaxis was in hibited by 10-4 g/ml CCAq in both cases. When CCAq was added to the mixture at the same time for testing the effect of the generation of chemotactic factor, a stronger action was observed.
NTS nephritis in the rat: The changes of proteinurea and serum complement level in NTS nephritis rats and the effect of CCAq are shown in Fig. 1 . In the control rats, biphasical increase of proteinurea and decrease of complement level were recognized. Increase of proteinurea was inhibited by adminis tration of 100 mg/kg CCAq i.p. for a 5 day period after the injection of NTS. However, the decrease of serum complement level was not influenced by CCAq. In the light micro scopical studies by HE and PAS staining, the histological score was counted by the degree of hypercellularity, hyalulosis, thickness of GBM or narrowing the capillary lumen. No significant difference was found between the control and the CCAq groups by Wilcoxon's U-test. By the immunofluorescence study, deposition of antibody and complement was not affected by administration of CCAq. The effect of CCAq on nephritis induced by the Complement was incubated with CCAq at 20'C for 1 hr before measurement of the activity. Values are presented as the means ±S.E. of 6 experiments. Significant difference from the control by the t-test, t: P<0.01. B: CCAq was added to lower chamber of the Boyden's chemotactic apparatus.
Significant difference from the control by the t-test, t: P<0.01.
Fig. 1. Effect of CCAq on NTS nephritis in rats .
Results are the means of 6 to 8 animals. The standard error is not shown for clarity, but it is less than 30.2% of the mean value for all points. Significant difference from the corresponding control value was calculated by the t-test, *: P<0.05. 0: Control, •: 50 mg/kg CCAq, A: 100 mg/kg CCAq. F(ab')2 of the nephrotoxic IgG antibody is indicated in Fig. 2 . The injection of F(ab')2 caused temporally proteinurea with no effect on the complement level between 1 and 7 days. Proteinurea caused by the F(ab')2 antibody was not affected by administration of CCAq. The histological score of the CCAq administered group was not different from the control. CCAq did not influence the histological changes.
Arthus reaction:
The effect of CCAq on the Arthus reaction is indicated in Fig. 3 . The intensity of the gross reaction was expressed as a dimension of inflammation consisting of redness, edeme, or necrosis. The severity of the reaction was greatly reduced by i.p. administration of 100 mg/kg CCAq, but not by 50 mg/kg at 2 hr prior to the injection of antigen.
Contact dermatitis: Guinea pigs received CCAq in doses of 50 to 200 mg/kg or prednisolone in a dose of 5 mg/kg i.p. at 2 hr prior to the challenge. As shown in Table 7 , the amount of dye in the blue lesion was not inhibited by the administration of CCAq. However, the reaction was significantly inhibited by prednisolone (P<0.05). HPFC: The effect of CCAq on HPFC production was compared with that of CoVF. Each drug was administered i.p. for 5 days after the immunization. As shown in Table 8 , CCAq had a tendency to decrease the production of HPFC. On the other hand, CoVF clearly suppressed the formation of H PFC. The standard error is not shown for clarity, but it is less than 29.4% of the mean value for all points. Significant difference from corresponding control value was calculated by the t-test, t: P<0.01. 0: Control, 0: 50 mg/kg CCAq, A: 100 mg/kg CCAq. It dose not affect the nephritis caused by the F(ab')2 of the nephrotoxic IgG antibody which is not able to activate the complement system. In addition, to these evidences, CCAq was shown to inhibit the immunological hemolysis by complement and inhibits the generation of chemotactic factor from complement.
These findings clearly suggest that CCAq has an anti-complement activity.
There have been many efforts to develop a new anti-allergic drug through the inhibition of complement activity. Anti-complement agents which have an anti-allergic action so far reported are aromatic amino acids and their derivatives, fumaropimaric acid, Cu chlorophyllin, and CoVF (24) (25) (26) . Most of them have indicated the inhibition of comple ment independent allergic reactions as well as the complement dependent reaction. These evidences have suggested that their anti-allergic actions are not always explained by their anti-complement activity. They have other inhibitory mechanisms towards the allergic reaction besides the anti-complement activity, for example, the inhibition of enzyme activity or mediators. Contrary to the reported agents, CCAq has indicated the inhibition of only complement dependent reactions. At the present stage, it is difficult to determine whether or not a specific complement inhibitor is more useful than a non-specific comple ment inhibitor. CCAq could be applied in complement dependent diseases.
Furthermore, it is considered that the mechanisms of anti-allergic actions of anti complemental agents are classified into three categories: the first is the inhibition of cytolysis caused by the chain reaction of complement components, the second is the inhibition of inflammatory activity of com plement fragments, and the third is inhibition of antibody formation through the C3 receptor on B lymphocytes or macrophages. CCAq had indicated inhibition of these three responses.
With respect to the anti-allergic action of complement inhibitors, experiments for testing the effect of agents on the activity of phlogistic complement fragments seem to be the most important. CCAq has indicated clear inhibition of the activity and generation of phlogistic complement components.
It is well known that the phlogistic components are C5a, C3a, and in some cases together with the trimolecular complex C567. These components are able to cause the capillary vasculitis and attraction of polymorphonuclear cells in an inflammatory lesion. In the present study, the generation of which component is inhibited by CCAq is not certain. Further experiments to investigate the effect of CCAq on each of the individual complement com ponents are needed.
In conclusion, CCAq has shown a potent anti-complemental activity in vitro and in vivo, but its detailed mechanisms are not clear. Since there are some clinical reports that indicate the importance of complement in some kinds of chronic organ inflammation (27) (28) , CCAq might be one of the effective kinds of remedies for some imflammatory disorders. Further experiments will be done to determine whether or not CCAq can be applied to some specific organ inflammation.
